TGen and Huntsman Cancer Institute receive $6.7 million grant to battle a hidden enemy

PHOENIX, Ariz. — May 30, 2018 — Often what kills cancer patients is not the cancer at its original or primary site, but its spread to secondary sites within the body, through a process called metastasis. In the case of breast cancer, the tumor often spreads to the bone, and it is this bone metastasis that results in intense pain and precedes the cancer’s spread to other organs.

In an effort to combat metastatic breast cancer, the U.S. Department of Defense has jointly awarded a $6.7 million grant to Huntsman Cancer Institute (HCI) at the University of Utah, and the Translational Genomics Research Institute (TGen), an affiliate of City of Hope.

With this new funding, HCI will focus on the biology of an important cellular pathway in metastatic breast cancer, while TGen will focus on drug development and supervise clinical trials to test those drugs.

“This is a critical unmet medical need. Cancer that has spread to the bone can cause unbearable pain for these patients,” said Dr. Jeffrey Trent, TGen President and Research Director. “For the first time, this team’s novel approach will seek to uncover this hidden cancer and enlist an immune response while at the same time preventing further damage


Article originally posted at

Click here for the full story

CategoryAggregator News

Privacy Policy / Terms Of Use

Powered by MMD